
medudoc
Bridging the digital gap of evolved patient expectations, arbitrary regulations and economical pressured healthcare providers like hospitals and doctors.
Date | Investors | Amount | Round |
---|---|---|---|
- | investor | €0.0 | round |
N/A | €0.0 | round | |
N/A | €0.0 | round | |
* | €2.0m | Angel | |
Total Funding | 000k |
USD | 2021 | 2022 | 2023 |
---|---|---|---|
Revenues | 0000 | 0000 | 0000 |
% growth | - | 110 % | - |
EBITDA | 0000 | 0000 | 0000 |
Profit | 0000 | 0000 | 0000 |
EV | 0000 | 0000 | 0000 |
EV / revenue | 00.0x | 00.0x | 00.0x |
EV / EBITDA | 00.0x | 00.0x | 00.0x |
R&D budget | 0000 | 0000 | 0000 |
Source: Dealroom estimates
Related Content
Headquartered in Lucerne, Switzerland, with a significant presence in Berlin, medudoc is a digital health company founded in 2019 to address inefficiencies in patient education and the informed consent process. The concept originated from the direct experience of a Chief Physician in a neurosurgery department in Switzerland who identified a critical need for a more effective, standardized, and patient-centric communication tool. The company was co-founded by Michael Horacek, Mona Ciotta, and Dennis Beyer. Horacek brings over 20 years of entrepreneurial experience in building healthcare companies, Ciotta has a background in business, marketing, and consulting, and Beyer contributes a decade of experience in digital innovation and company building.
medudoc operates on a business-to-business (B2B) software-as-a-service (SaaS) model, targeting hospitals, specialized medical centers, and regional healthcare providers. Its revenue is generated through subscription fees, offering various plans such as "FLEX Abo," "SPAR Abo," and single licenses. The company primarily serves the German, Austrian, and Swiss (DACH) markets, where it has established a footprint across numerous hospitals. The core of medudoc's offering is an intelligent platform that digitizes, automates, and personalizes patient education. It utilizes a library of over 4,000 medically validated video clips to generate customized educational videos tailored to a patient's specific procedure, risks, and medical profile. This approach aims to replace traditional, paper-based consent forms, which are often difficult for patients to comprehend and administratively burdensome for clinical staff. Studies conducted with university hospitals have shown that the platform can reduce the time spent on consent processes by over 50%.
The platform is designed for seamless integration into existing hospital information systems (HIS) and patient portals via APIs, minimizing disruption to clinical workflows. A key feature is the legally compliant electronic signature capability, which adheres to eIDAS and ISO 27001 standards, allowing for a fully digital and secure informed consent process. By providing educational content to patients at home before their appointments, medudoc helps reduce patient anxiety and procedure cancellation rates. Following its founding idea in 2019, the company spent 2020 in validation and clinical testing, officially launching in its first clinic in November 2021. By 2022, medudoc had secured approximately $1.98 million in a seed funding round from business angels to fuel its expansion in the DACH region and prepare for entry into the UK market.
Keywords: digital patient education, informed consent, healthtech, SaaS, clinical workflow automation, medical communication, e-signature, patient engagement, healthcare documentation, DACH healthcare market, hospital information systems integration, medical video library, surgical preparation, patient-centered care, clinical efficiency, medudoc, Michael Horacek, Mona Ciotta, Dennis Beyer, telemedicine platform